United by a drive to redesign the infrastructure, practice, and experience of medicine

Brett Shaheen, CEO of Redesign Health, is a healthcare investor, entrepreneur, and operator whose work has spanned company building and investing across multiple asset classes. Brett was previously a partner and lead healthcare analyst at Lone Pine Capital and a private equity associate at the Carlyle Group. He began his career as an analyst at Goldman Sachs and spent time at Google and the Boston Consulting Group. Brett holds an MBA from Harvard Business School, received a Master of Philosophy in International Relations from Christ Church, Oxford University, where he studied as a Rhodes Scholar, and graduated summa cum laude with a BS and BA from The Wharton School, University of Pennsylvania.

For four decades, Dr. Stephen Klasko has connected worlds too often kept apart: Silicon Valley and medical academia, business and medicine, scientific rigor and creative imagination. As CEO and Chair of the Health Assurance Foundation (HAF), he leads a philanthropic platform that accelerates the shift from sick care to proactive, personalized, and affordable support at every address. HAF builds the workforce, education, credentials, equity, trust, and accountability that technology alone cannot deliver. Through grants, coalitions, and real-world demonstrations, it brings together health systems, universities, standards bodies, payers, patients, and caregivers to redesign work before displacement and prepare people for emerging health professions. HAF is building an Agentic Alliance and a Caregiver Alliance as a unified workforce of care, connecting safe, accountable human-AI teams with supported family and community caregivers. Its approach: Connect, Convene, Coach, Credential, and Compensate links preparation and employer-recognized competencies to sustainable payment pathways, with equity built in from the start. As President and CEO of Thomas Jefferson University and Jefferson Health, he expanded a $1.8 billion regional organization into a $10 billion enterprise and merged a health sciences university with a nationally ranked design school. Jefferson became the nation's fastest-growing academic medical center. Modern Healthcare ranked him #2 among its “100 Most Influential People in Healthcare,” and Fast Company named him one of its most creative people in business. He also chairs Redesign Health, a global venture and applied technology firm that has joined forces with ARC Global, founded at Sheba Medical Center, and acquired AVIA, a digital transformation partner that helps health systems select, implement, and scale digital and AI solutions. Together, they work with more than 100 health systems across five continents to turn frontline ideas into companies and bring innovative technologies into widespread use. An OB/GYN by training and a former dean of two medical colleges, he has chaired NYSE- and Nasdaq-listed companies, served as Executive in Residence at General Catalyst, and been a presidential appointee to the National Board of Education. The author of seven books, Klasko co-wrote UnHealthcare: A Manifesto for Health Assurance with Hemant Taneja, helping shape General Catalyst's health assurance investment strategy. His forthcoming Hitchhiker's Guide to the Healthcare Galaxy explores healthcare's future through a time- traveling lens. He is also a vinyl-spinning DJ, a distance runner, and a graduate literature student at Northwestern University: proof that he takes his own advice about bringing different worlds together.

Prof. Zimlichman serves as Chief Innovation & AI at Sheba Medical Center (Sheba). To redesign healthcare to be more patient-centric, effective, efficient, and equitable, he founded Sheba’s innovation arm, ARC. ARC is short for accelerate, redesign, and collaborate. In the United States, Prof. Zimlichman held the position of lead researcher at Partners HealthCare's Clinical Affairs Department in Boston, where he was involved in strategic care redesign efforts. During that time, Prof. Zimlichman had appointments at Brigham and Women’s Hospital and Harvard Medical School's affiliate, the Center for Patient Safety Research and Practice. Prof. Zimlichman is a founding member of the International Academy of Quality and Safety in Health Care and an international expert at the International Society of Quality in Healthcare. He also served as an advisor to the Office of the National Coordinator for Health Information Technology in the U.S. Department of Health and Human Services. Prior to assuming his current position, he was Chief Medical Officer and Chief Quality Officer at Sheba. Prof. Zimlichman earned his MSc in Healthcare Management from the Harvard Chan School of Public Health and his MD from the Technion Israel Institute of Technology.

Aron leads technology and AI investments, operations, and product development at Redesign Health and across the portfolio. At PathAI and Kensho, he built AI platforms worth over $1B that continue to shape workflows for hundreds of thousands of experts in cancer diagnostics, financial analysis, and counterterrorism. Before joining Redesign, Aron led technology and AI for the world's foremost clinical trial in Parkinson's disease. He held research and teaching positions at Harvard University, where he studied mathematics, computational economics, and philosophy, graduating Phi Beta Kappa with highest honors. His graduate research introduced the first machine learning technique for detecting disinformation on social networks and was awarded the Fay Prize for the most outstanding work at Harvard in any field. Aron is an active concert cellist and performs and records with ensembles worldwide.

Nathan is the General Counsel and Corporate Secretary at Redesign Health, where he leads the Legal, Policy & Compliance team and advises the company's leadership and Board of Directors on legal, regulatory, and strategic matters. Alongside his core legal work, Nathan designs, codes, and deploys AI-enabled tools that process, extract, categorize, and analyze high-volume legal and business data. He has decades of experience advising public and private companies on domestic and international capital markets, mergers and acquisitions, complex transactions, and corporate governance. Nathan earned a BA from Trinity College, an MSc from the London School of Economics, and a JD from the University of Pennsylvania Law School.

Neil is the Head of Investing at Redesign Health. With nearly 20 years in the healthcare industry, Neil brings extensive experience as an operator, consultant, and early-stage investor. Previously, Neil was the Head of Partner Strategy and Solutions for AWS Healthcare after serving as CEO of Healthbox and leading its turnaround and sale to HIMSS. Neil holds an MBA from Northwestern University and a BS in Biomedical Engineering from Johns Hopkins University.

Samantha is the Head of Strategy and Finance at Redesign Health. She has twenty years of experience identifying growth opportunities for technology, e-commerce, and media businesses, coupled with deep fundraising and mergers and acquisitions experience. Samantha spent five years at Compass, leading corporate development, investor relations, and strategic finance. She raised over $1B in funding, driving the valuation from $800M to over $6B, closed fifteen acquisitions, and launched agent and seller loan programs. Before that, Samantha was an early-stage venture investor at BBG Capital, a strategy consultant at Activate, a member of the corporate development team at News Corporation, and an analyst at Goldman Sachs. She graduated magna cum laude from the School of Public and International Affairs at Princeton University and received an MBA from Harvard Business School.

Sarah is the Head of Platform at Redesign Health, where she leads firm-wide operational excellence and co-leads the venture capital business. She previously worked at Andela, guiding the organization through a major transformation into a global talent marketplace, and at Medallia, where she led talent development and strategy and partnered with enterprise clients to shape their customer experience strategies. Sarah began her career in management consulting at Deloitte. She holds a Bachelor of Law in Law and French from the University of Leeds, including a year at Université Toulouse Capitole, and is a certified coach.

Adam Jones has more than fifteen years of international, strategy, and partnership building experience. Prior to joining Redesign, Adam served as Chief of Staff at Pie Insurance, a growth stage insurance technology company, where he led fundraising, strategy formation, and operational tracking, and served as primary Board liaison. Before Pie, he led strategy, fundraising, international expansion efforts at Datawallet, an early stage data technology company, and worked in the Investment Banking Division at Morgan Stanley, where he advised healthcare clients on M&A and debt and equity raises globally. Adam began his career as an officer in the United States Navy, where he served in Japan, Iraq, the Pentagon and White House. Adam earned a BS in Economics from the United States Naval Academy, MA in Global Security Studies from Johns Hopkins, and an MBA from Harvard Business School.

Akhilesh is Managing Director of Ventures at Redesign Health. He was previously a Partner at MVM where he invested in high growth healthcare companies, and prior to that he practiced medicine. His research on healthcare systems has led to more than a dozen academic publications and 50 articles in the popular press, including in The Washington Post and Scientific American. Akhilesh holds an MD and MBA from Stanford University, and an AB from Harvard College.

Brett is the Senior Director of Operations and People at Redesign Health, where he also serves as Chief of Staff. Previously, he worked as an early-stage startup operator and built founder and startup ecosystems with Venture For America across the United States. At Redesign, Brett drives the operational foundation and high-performing culture behind the company’s ambitions.

Clark is a Senior Director of Strategy and Finance at Redesign Health. He brings experience in M&A advisory and growth investing, as well as early stage startup operations. Prior to Redesign, he led the finance function and acquisition of Qapital, a financial technology company, and was a founding team member at Incentrum, a Merchant Bank. He holds a BA in Economics from Northwestern University.

Dan is the VP of Applied AI at Redesign Health, focused on developing frontier-quality AI tools to improve outcomes for founders. Prior to joining Redesign, Dan was the youngest partner at Citi using AI tools to advise on tech mergers, led the data team for private markets FinTech Yieldstreet, and founded the Data Science team at Goldman Sachs. Dan graduated with honors from Williams College in 2011 where he majored in Math and Economics, and won 2 rowing national championships.

Leland is the Head of Venture Traction at Redesign Health. He came to the role as an investor, operator, and builder having backed early-stage digital health companies through the Intermountain Innovation Fund at Healthbox, then joined Homethrive as one of its first ten employees to build and scale its tech-enabled caregiving platform. Leland holds an MBA from Chicago Booth and a BA in Chemistry and Economics from Williams College.

Meela Imperato is an entrepreneur, investor, and seasoned brand builder with more than a decade of experience launching and scaling startups. As a growth driver, she has worked across many industries—most notably in healthtech, fertility, and fitness—helping founders turn business strategies into compelling brand stories. In her current role as VP of Marketing at Redesign Health, Meela leads brand and growth efforts across the firm’s platform and portfolio, partnering with founders to build and scale healthcare companies that improve how people live, age, and access care, with a deep focus on consumer and women’s health. Throughout her career, Meela has successfully led marketing teams at high-growth startups like Aaptiv, Noom, Seated, and Jumprope (Acquired by Linkedin). As a marketing and growth consultant, she has spearheaded brand and product initiatives for industry giants like Google, Lyft, Peloton, and SoulCycle and helped early-stage startups like Berry Fertility, SoWell Health, Briefly, Vestwell, and Yumi build strong marketing foundations and unlock growth potential. Meela holds dual Master’s degrees in Professional Writing and Investigative Journalism and dual Bachelor’s degrees in Creative and Professional Writing from Carnegie Mellon University. She currently serves on the Carnegie Mellon University Alumni Association Board. Her passion for improving healthtech, particularly women’s health, stems from the years of medical and fertility challenges she faced when expanding her family.

Mie is the Head of Capital Development at Redesign Health. With over a decade spent in various roles across banking and capital formation, Mie brings extensive experience to the strategic finance team. Previously, Mie spent 8 years at J.P. Morgan, most recently on the Morgan Private Capital team which offers sophisticated investors access to exclusive direct investment opportunities from across the firm. Mie holds a BA from Duke University in Political Science where she was also captain of the varsity women’s lacrosse team.